| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 49.13M | — |
| Operating expense | — | — |
| Net income | -8.91M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AKBA returned -71.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -43.7% |
| 1 year | -71.6% |
| 5 years | -69.2% |
| 10 years | -88.8% |
| All-time high | $27.79 (Jun 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AKBA would be worth today ›No. Akebia Therapeutics, Inc. has not paid a dividend in the past 12 months.
Akebia Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol AKBA.
Akebia Therapeutics, Inc. is part of the Healthcare sector.
Akebia Therapeutics, Inc. has a market cap of 251.22M USD, based on the latest quote.
